Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Man experienced lasting sexual dysfunction from finasteride, but malpractice claim was rejected.

Female and male AGA are different diseases.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

About 50% of 46, XY DSD cases lack a genetic diagnosis, but advanced sequencing methods improve detection.

Alopecia affects self-confidence, body image, and social interactions, causing distress and requiring better support and awareness.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Finasteride does not cause sexual dysfunction in men with hair loss.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Mantel's family life affected her view of femininity and worsened her endometriosis.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Women and people with skin of color are more likely to be misdiagnosed with alopecia areata.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Alopecia affects identity and social interactions, requiring personalized support and better healthcare collaboration.

Atypical male hair loss may not respond to usual treatments.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.